Andre Hoffmann
Angel investor in Switzerland
Switzerland
Andre Hoffmann, Angel investor in Switzerland is an active investor based in Switzerland. This profile covers what Andre Hoffmann backs, at which stage, and how founders can reach out in 2026.
Mr. Andre Hoffmann serves as Chairman at Massellaz. Mr. Hoffmann is an Angel Investor. He serves as Board Member at SystemiQ. He is an Angel Investor. He serves as Vice Chairman, Chairman of the Corporate Governance and Sustainability Committee, Chairman of the Remuneration Committee, and Member of the Nomination Committee at Roche. He serves as Inovalon. He serves as the President of the Board at the W. A. de Vigier Foundation. Since 2006, He serves one of the world's largest diversified healthcare companies focused on medical diagnostics and treatments, and has served as a board member since 1996. Mr. Hoffmann also has served as Non-Executive Vice Chairman of Givaudan SA, the world's leading flavor and fragrance company, since 2008 and as a non-executive member of the board of directors since 2000. Since 1999, Mr. Hoffmann also has served as the Chairman and owner of Massellaz S.A., a research and advisory company, and, from 2005 to 2013, served as the Chairman and owner of Nemadi Advisors Ltd., a private equity advisory company. Mr. Hoffmann also serves as a director for Genentech Inc., one of the world's largest biotechnology companies, ultimately acquired by Roche, Amazentis SA, a private therapeutics and diagnostics company, and Glyndebourne Productions Ltd., a service company. Also, he serves as a Board member at GIST Impact. He holds an MBA from INSEAD and a degree in Economics from the University of St. Gallen.
- Investor type
- Angel
- Stages
- Early Stage VentureSeedLate Stage Venture
- Invests in
- Healthcare & BiotechClimate & EnergyConsumer & RetailFood & Beverage
- Location
- Switzerland
- Typical check
- $500K
- Past investments
- 16
Notable investments
Gist
INSEADSYSTEMIQ Ltd.Basecamp ResearchNatural Capital ResearchThe Landbanking Group
Pomelo FashionCapitals CoalitiongivaudanHow to reach Andre Hoffmann
Angels and operators like Andre Hoffmann reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Reach active investors like this one
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Andre Hoffmann." Round Funded investor database, updated September 9, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/investor/andre-hoffmann-167909-8
Frequently Asked Questions
What does Andre Hoffmann invest in?
Andre Hoffmann invests in Healthcare & Biotech, Climate & Energy, Consumer & Retail and Food & Beverage, typically at Early Stage Venture, Seed and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Andre Hoffmann invest at?
Andre Hoffmann typically invests at Early Stage Venture, Seed and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Andre Hoffmann's typical check size?
Andre Hoffmann typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.
How do founders reach investors like this?
Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.